CompoAtlas

Unicity Cleanse Tea

Unicity Cleanse Tea : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

Registration number
MAL23106114TC
Type
Natural product
Published status
PRODUCT APPROVED
Licence holder
UNICITY IMPORTS MALAYSIA SDN. BHD.
Manufacturer
Unicity Global Manufacturing USA
Importer
UNICITY IMPORTS MALAYSIA SDN. BHD.
Registration period starting
2023-10-19
Published validity end
2028-10-19

The foreign register category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

No point flagged by the rules applied to recognised ingredients.

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Published ingredientPublished text and quantityIdentified nutrient or substance
Chamaemelum nobileChamaemelum nobile[6.05 mg,960.03 mg]Not identified
Lonicera japonicaLonicera japonica[6.05 mg,960.03 mg]Not identified
Althaea officinalisAlthaea officinalis[30.34 mg,960.03 mg]Not identified
Rosa caninaRosa canina[40.46 mg,960.03 mg]Not identified
Citrus sinensisCitrus sinensis[50.54 mg,960.03 mg]Not identified
Arctostaphylos uva ursiArctostaphylos uva ursi[50.54 mg,960.03 mg]Not identified
Mentha piperitaMentha piperita[141.46 mg,960.03 mg]Not identified
Cassia angustifoliaCassia angustifolia[493.13 mg,960.03 mg]Not identified
Rhamnus frangulaRhamnus frangula[141.46 mg,960.03 mg]Not identified

The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.

Original register data

View published fields and their variants
Active ingredients
Chamaemelum nobile[6.05 mg,960.03 mg],Lonicera japonica[6.05 mg,960.03 mg],Althaea officinalis[30.34 mg,960.03 mg],Rosa canina[40.46 mg,960.03 mg],Citrus sinensis[50.54 mg,960.03 mg],Arctostaphylos uva ursi[50.54 mg,960.03 mg],Mentha piperita[141.46 mg,960.03 mg],Cassia angustifolia[493.13 mg,960.03 mg],Rhamnus frangula[141.46 mg,960.03 mg]
Valid until
2028-10-19
Registration date
2023-10-19
Published description
NATURAL PRODUCT
Licence holder
UNICITY IMPORTS MALAYSIA SDN. BHD.
Importer
UNICITY IMPORTS MALAYSIA SDN. BHD.
Producer
Unicity Global Manufacturing USA
Published name
Unicity Cleanse Tea
Published reference
2023042011122T
Registration number
MAL23106114TC
Published status
PRODUCT APPROVED

Official source

View the official register, number MAL23106114TC

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Chamaemelum nobile
    Read the warning, when it applies and the studies cited

    Roman Chamomile - Chamaemelum Nobile

    Route of administration: Oral (Wichtl 2004; Bradley 1992)

    Cautions and warnings

    Ask a healthcare practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (Brinker 2010; Mills and Bone 2000; Blumenthal et al. 1998).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 27 March 2026

  • Althaea officinalis
    Read the warning, when it applies and the studies cited

    Marshmallow - ALTHAEA OFFICINALIS - Root

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Health Canada monograph dated 19 December 2025

    MARSHMALLOW - ALTHAEA OFFICINALIS - LEAF

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Health Canada monograph dated 29 November 2024

  • Mentha piperita
    Read the warning, when it applies and the studies cited

    PEPPERMINT - MENTHA X PIPERITA

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have gallstones or anemia (Brinker 2010; Mills and Bone 2005; Blumenthal et al. 2000).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: Essential oil.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have hiatus hernia or gastroesophageal reflux (Brinker 2010; Mills and Bone 2005; ESCOP 2003).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Condition of application: Essential oil.

    When using this product you may experience gastroesophageal reflux (Brinker 2010; Mills and Bone 2005; ESCOP 2003).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Stop use if hypersensitivity/allergy occurs (Mills and Bone 2005; ESCOP 2003).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 27 February 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line